Literature DB >> 22761181

MAFbx, MuRF1, and the stress-activated protein kinases are upregulated in muscle cells during total knee arthroplasty.

Ashley N Bailey1, Austin D Hocker, Benjamin R Vermillion, Keith Smolkowski, Steven N Shah, Brian A Jewett, Hans C Dreyer.   

Abstract

Total knee arthroplasty (TKA) is the most common and a cost-effective surgical remediation for older adults with long-standing osteoarthritis. In parallel with the expanding population of older adults, the number of TKAs performed annually is projected to be 3.48 million by 2030. During this surgery, a tourniquet is used to stop blood flow to the operative leg. However, the molecular pathways that are affected by tourniquet use during TKA continue to be elucidated. We hypothesized that components of the catabolic FoxO3a (i.e., MuRF1, MAFbx, and Bnip3) pathway, as well as the cellular stress pathways [i.e., stress-activated protein kinase (SAPK)/JNK and MAPKs], are upregulated during TKA. The purpose of this study was to measure changes in transcripts and proteins involved in muscle cell catabolic and stress-activated pathways. We obtained muscle biopsies from subjects, 70 ± 1.3 yr, during TKA, from the vastus lateralis at baseline (before tourniquet inflation), during maximal ischemia (just before tourniquet release), and during reperfusion. Total tourniquet time was 43 ± 2 min and reperfusion time was 16 ± 1. Significant increases in FoxO3a downstream targets, MAFbx and MuRF1, were present for mRNA levels during ischemia (MAFbx, P = 0.04; MuRF1, P = 0.04), and protein expression during ischemia (MAFbx, P = 0.002; MuRF1, P = 0.001) and reperfusion (MuRF1, P = 0.002). Additionally, stress-activated JNK gene expression (P = 0.01) and protein were elevated during ischemia (P = 0.001). The results of this study support our hypothesis that protein degradation pathways are stimulated during TKA. Muscle protein catabolism is likely to play a role in the rapid loss of muscle volume measured within 2 wk of this surgery.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22761181      PMCID: PMC3423996          DOI: 10.1152/ajpregu.00146.2012

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  44 in total

1.  Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030.

Authors:  Steven Kurtz; Kevin Ong; Edmund Lau; Fionna Mowat; Michael Halpern
Journal:  J Bone Joint Surg Am       Date:  2007-04       Impact factor: 5.284

2.  FoxO3 controls autophagy in skeletal muscle in vivo.

Authors:  Cristina Mammucari; Giulia Milan; Vanina Romanello; Eva Masiero; Ruediger Rudolf; Paola Del Piccolo; Steven J Burden; Raffaella Di Lisi; Claudia Sandri; Jinghui Zhao; Alfred L Goldberg; Stefano Schiaffino; Marco Sandri
Journal:  Cell Metab       Date:  2007-12       Impact factor: 27.287

Review 3.  Dynamic FoxO transcription factors.

Authors:  Haojie Huang; Donald J Tindall
Journal:  J Cell Sci       Date:  2007-08-01       Impact factor: 5.285

4.  The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments.

Authors:  Stephen A Bustin; Vladimir Benes; Jeremy A Garson; Jan Hellemans; Jim Huggett; Mikael Kubista; Reinhold Mueller; Tania Nolan; Michael W Pfaffl; Gregory L Shipley; Jo Vandesompele; Carl T Wittwer
Journal:  Clin Chem       Date:  2009-02-26       Impact factor: 8.327

5.  Identification of essential sequences for cellular localization in the muscle-specific ubiquitin E3 ligase MAFbx/Atrogin 1.

Authors:  Lagirand-Cantaloube Julie; Batonnet-Pichon Sabrina; Leibovitch Marie-Pierre; Serge A Leibovitch
Journal:  FEBS Lett       Date:  2012-01-11       Impact factor: 4.124

Review 6.  Signalling to translation: how signal transduction pathways control the protein synthetic machinery.

Authors:  Christopher G Proud
Journal:  Biochem J       Date:  2007-04-15       Impact factor: 3.857

7.  Muscle sparing in muscle RING finger 1 null mice: response to synthetic glucocorticoids.

Authors:  Leslie M Baehr; J David Furlow; Sue C Bodine
Journal:  J Physiol       Date:  2011-08-01       Impact factor: 5.182

Review 8.  The BCL-2 family reunion.

Authors:  Jerry E Chipuk; Tudor Moldoveanu; Fabien Llambi; Melissa J Parsons; Douglas R Green
Journal:  Mol Cell       Date:  2010-02-12       Impact factor: 17.970

9.  The long-term contribution of muscle activation and muscle size to quadriceps weakness following total knee arthroplasty.

Authors:  Whitney A Meier; Robin L Marcus; Leland E Dibble; K Bo Foreman; Christopher L Peters; Ryan L Mizner; Paul C LaStayo
Journal:  J Geriatr Phys Ther       Date:  2009       Impact factor: 3.381

10.  Inhibition of atrogin-1/MAFbx mediated MyoD proteolysis prevents skeletal muscle atrophy in vivo.

Authors:  Julie Lagirand-Cantaloube; Karen Cornille; Alfredo Csibi; Sabrina Batonnet-Pichon; Marie Pierre Leibovitch; Serge A Leibovitch
Journal:  PLoS One       Date:  2009-03-25       Impact factor: 3.240

View more
  10 in total

1.  Essential amino acid supplementation alters the p53 transcriptional response and cytokine gene expression following total knee arthroplasty.

Authors:  Jonathan B Muyskens; Ari Winbush; Douglas M Foote; Douglas W Turnbull; Hans C Dreyer
Journal:  J Appl Physiol (1985)       Date:  2020-09-03

2.  AICAR administration ameliorates hypertension and angiogenic imbalance in a model of preeclampsia in the rat.

Authors:  Christopher T Banek; Ashley J Bauer; Karen M Needham; Hans C Dreyer; Jeffrey S Gilbert
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-02-15       Impact factor: 4.733

3.  Global deletion of BCATm increases expression of skeletal muscle genes associated with protein turnover.

Authors:  Christopher J Lynch; Scot R Kimball; Yuping Xu; Anna C Salzberg; Yuka Imamura Kawasawa
Journal:  Physiol Genomics       Date:  2015-09-08       Impact factor: 3.107

4.  Perioperative assessment of muscle inflammation susceptibility in patients with end-stage osteoarthritis.

Authors:  Devin J Drummer; Jeremy S McAdam; Regina Seay; Inmaculada Aban; Kaleen M Lavin; Derek Wiggins; Gabriel Touliatos; Sufen Yang; Christian Kelley; S Craig Tuggle; Brandon Peoples; Herrick Siegel; Elie Ghanem; Jasvinder A Singh; Scott Schutzler; C Lowry Barnes; Arny A Ferrando; S Louis Bridges; Marcas M Bamman
Journal:  J Appl Physiol (1985)       Date:  2022-03-03

Review 5.  Skeletal muscle atrophy and the E3 ubiquitin ligases MuRF1 and MAFbx/atrogin-1.

Authors:  Sue C Bodine; Leslie M Baehr
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-08-05       Impact factor: 4.310

6.  Essential amino acid supplementation in patients following total knee arthroplasty.

Authors:  Hans C Dreyer; Lisa A Strycker; Hilary A Senesac; Austin D Hocker; Keith Smolkowski; Steven N Shah; Brian A Jewett
Journal:  J Clin Invest       Date:  2013-10-25       Impact factor: 14.808

Review 7.  Tourniquet Use During Knee Replacement Surgery May Contribute to Muscle Atrophy in Older Adults.

Authors:  Hans C Dreyer
Journal:  Exerc Sport Sci Rev       Date:  2016-04       Impact factor: 6.230

8.  Endoplasmic Reticulum Stress Activation during Total Knee Arthroplasty.

Authors:  Austin D Hocker; Ryan M Boileau; Brick A Lantz; Brian A Jewett; Jeffrey S Gilbert; Hans C Dreyer
Journal:  Physiol Rep       Date:  2013-08-01

9.  Transcriptional profiling and muscle cross-section analysis reveal signs of ischemia reperfusion injury following total knee arthroplasty with tourniquet.

Authors:  Jonathan B Muyskens; Austin D Hocker; Douglas W Turnbull; Steven N Shah; Brick A Lantz; Brian A Jewett; Hans C Dreyer
Journal:  Physiol Rep       Date:  2016-01

10.  Pharmacological treatment with inhibitors of nuclear export enhances the antitumor activity of docetaxel in human prostate cancer.

Authors:  Giovanni Luca Gravina; Andrea Mancini; Alessandro Colapietro; Francesco Marampon; Roberta Sferra; Simona Pompili; Leda Assunta Biordi; Roberto Iorio; Vincenzo Flati; Christian Argueta; Yosef Landesman; Michael Kauffman; Sharon Shacham; Claudio Festuccia
Journal:  Oncotarget       Date:  2017-11-30
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.